Gland Pharma Limited has informed the Exchange about Gland Pharma receives GMP Compliance Certificate from the Danish MedicinesAgency for aseptically prepared Powder for injection, infusion and inhalation
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma's Pashamylaram manufacturing facility has received a Good Manufacturing Practices (GMP) Compliance Certificate from the Danish Medicines Agency. The certification covers aseptically prepared powder for injection, infusion, and inhalation products. It is specifically for marketing authorizations that list manufacturers located outside the European Economic Area. The certification enables the facility to supply these products to Denmark and potentially other EU/EEA markets.
This regulatory approval strengthens Gland Pharma's export credentials in Europe and supports its ability to win and retain contracts in regulated markets. It is a positive operational milestone, though it does not directly impact near-term revenue unless followed by specific order wins.